Universität zu Köln

2018

Berlth, Felix ORCID: 0000-0002-3780-0728, Messerle, K., Plum, P. S., Chon, S. -H., von Ambueren, J., Hohn, A., Duebbers, M., Bruns, C. J., Moenig, S. P., Bollschweiler, E., Hoelscher, A. H. and Alakus, H. (2018). Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-Gastrectomy. World J.Surg., 42 (6). S. 1811 - 1819. NEW YORK: SPRINGER. ISSN 1432-2323

Hewitt, L. C., Inam, I. Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G. E., Melotte, V., Langley, R. E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G. G. and Grabsch, H. I. (2018). Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study. Eur. J. Cancer, 94. S. 104 - 115. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

2017

Celik, E., Bollschweiler, E., Semrau, R. and Marnitz-Schulze, S. (2017). Neoadjuvant chemotherapy or chemo-radiation for patients with advanced adenocarcinoma of the esophagus? A propensity score-matched study. Strahlenther. Onkol., 193. S. S42 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Favi, F., Bollschweiler, E., Berlth, F., Plum, P., Hecheler, D., Alakus, H., Semrau, R., Celik, E., Moenig, S. P., Drebber, U. and Hoelscher, A. H. (2017). Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study. EJSO, 43 (8). S. 1572 - 1581. OXFORD: ELSEVIER SCI LTD. ISSN 1532-2157

2015

Bludau, M., Hoelscher, A. H., Bollschweiler, E., Leers, J. M., Gutschow, C. A., Brinkmann, S. and Schroeder, W. (2015). Preoperative airway colonization prior to transthoracic esophagectomy predicts postoperative pulmonary complications. Langenbecks Arch. Surg., 400 (6). S. 707 - 715. NEW YORK: SPRINGER. ISSN 1435-2451

Celik, E., Bollschweiler, E., Kocher, M., Otten, V. and Semrau, R. (2015). Comparison of two Therapeutic Protocols in the neoadjuvant Radiochemotherapy of advanced Oesophageal Carcinoma. Strahlenther. Onkol., 191. S. S139 - 1. MUNICH: URBAN & VOGEL. ISSN 1439-099X

2014

Baltin, C. T. H., Zimmer, P., Bollschweiler, E., Hoelscher, A., Bloch, W. and Baumann, F. (2014). Status quo of the endurance performance capacity and physical strength of patients with esophageal and gastric cancer. Oncol. Res. Treat., 37. S. 48 - 49. BASEL: KARGER. ISSN 2296-5262

Bollschweiler, E., Baltin, C., Berlth, F., Moenig, S. P. and Hoelscher, A. H. (2014). Quality of life and visceral surgery. Chirurg, 85 (3). S. 203 - 208. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0385

2013

Bludau, M., Hoelscher, A. H., Vallboehmer, D., Metzger, R., Bollschweiler, E. and Schroeder, W. (2013). Vascular endothelial growth factor expression following ischemic conditioning of the gastric conduit. Dis. Esophagus, 26 (8). S. 847 - 853. CARY: OXFORD UNIV PRESS INC. ISSN 1442-2050

Odenthal, M., Bollschweiler, E., Grimminger, P. P., Schroeder, W., Brabender, J., Drebber, U., Hoelscher, A. H., Metzger, R. and Vallboehmer, D. (2013). MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Int. J. Cancer, 133 (10). S. 2454 - 2464. HOBOKEN: WILEY-BLACKWELL. ISSN 0020-7136

2012

Vallboehmer, D., Bollschweiler, E., Brabender, J., Wedemeyer, I., Grimminger, P. P., Metzger, R., Schroeder, W., Gutschow, C., Hoelscher, A. H. and Drebber, U. (2012). Evaluation of histological regression grading systems in the neoadjuvant therapy of rectal cancer. Int. J. Colorectal Dis., 27 (10). S. 1295 - 1302. NEW YORK: SPRINGER. ISSN 0179-1958

2010

Vallboehmer, D., Hoelscher, Arnulf H., DeMeester, S., DeMeester, T., Salo, J., Peters, J., Lerut, T., Swisher, S. G., Schroeder, W., Bollschweiler, E. and Hofstetter, W. (2010). A Multicenter Study of Survival After Neoadjuvant Radiotherapy/Chemotherapy and Esophagectomy for ypT0N0M0R0 Esophageal Cancer. Ann. Surg., 252 (5). S. 744 - 749. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1528-1140